Skip to main content
. 2014 Jul 22;3(4):e000907. doi: 10.1161/JAHA.114.000907

Table 2.

Association of BNP and NT‐proBNP (Entered as Log‐Transformed Continuous Variables, Per 1SD Increase) With Cardiovascular Outcomes

Log BNP Log NT‐proBNP
HR* (95% CI) P Value HR* (95% CI) P Value
HF
Model 1* 3.18 (2.65 to 3.80) <0.001 3.14 (2.70 to 3.65) <0.001
Model 2* 3.08 (2.56 to 3.70) <0.001 3.14 (2.69 to 3.68) <0.001
Model 3* 2.81 (2.12 to 3.74) <0.001 2.81 (2.09 to 3.78) <0.001
Nonfatal MI
Model 1* 1.65 (1.36 to 2.00) <0.001 1.80 (1.51 to 2.16) <0.001
Model 2* 1.60 (1.32 to 1.95) <0.001 1.76 (1.46 to 2.12) <0.001
Model 3* 1.43 (1.09 to 1.88) 0.01 1.77 (1.30 to 2.41) <0.001
CVA/TIA
Model 1* 1.64 (1.25 to 2.15) 0.001 1.66 (1.28 to 2.14) <0.001
Model 2* 1.64 (1.24 to 2.16) <0.001 1.68 (1.29 to 2.18) <0.001
Model 3* 1.37 (0.93 to 2.01) 0.11 1.40 (0.92 to 2.13) 0.12
CV death
Model 1* 1.90 (1.57 to 2.30) <0.001 2.36 (1.99 to 2.81) <0.001
Model 2* 1.90 (1.56 to 2.32) <0.001 2.40 (2.00 to 2.89) <0.001
Model 3* 1.61 (1.22 to 2.13) 0.001 2.19 (1.63 to 2.94) <0.001
Any event
Model 1* 1.96 (1.73 to 2.21) <0.001 2.20 (1.97 to 2.46) <0.001
Model 2* 1.94 (1.71 to 2.20) <0.001 2.19 (1.95 to 2.45) <0.001
Model 3* 1.58 (1.32 to 1.89) <0.001 1.84 (1.52 to 2.24) <0.001

BNP indicates brain‐type natriuretic peptide; CI, confidence interval; CV, cardiovascular; CVA, cerebral vascular accident; HF, heart failure; HR, hazard ratio; MI, myocardial infarction; NT‐proBNP, amino‐terminal fragment of the BNP prohormone; TIA, transient ischemic attack.

*

Adjusted for age, sex and ethnicity.

*

Adjusted for age, natural log of the ratio of total cholesterol to high‐density lipoprotein cholesterol, and diabetes for men and age, natural log of the ratio of total cholesterol to high‐density lipoprotein cholesterol, natural log of systolic blood pressure, diabetes, and smoking for women.

*

Adjusted for age, sex, ethnicity, diabetes mellitus, current smoking, history of heart failure, history of myocardial infarction, body mass index, systolic blood pressure, low‐density lipoprotein, estimated glomerular filtration rate, left ventricular mass index, left ventricular ejection fraction, and left ventricular diastolic function.